Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L van 't Veer
Abstract P3-10-06: Expression-Based Immune Signatures as Predictors of Neoadjuvant Targeted-/Chemo-Therapy Response: Experience From the I-Spy 2 TRIAL of ˜1000 Patients Across 10 Therapies
Related publications
Credibility of 10/20 Experience as Compared With 5/10 Experience, by Roberts Lewis H.
ASTIN Bulletin
Accounting
Economics
Econometrics
Finance
Chemotherapy Response and Recurrence-Free Survival in Neoadjuvant Breast Cancer Depends on Biomarker Profiles: Results From the I-Spy 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
Breast Cancer Research and Treatment
Cancer Research
Oncology
An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted Therapies
Clinical Cancer Research
Cancer Research
Oncology
Clinical Experience of Dual Targeted Blockade (Pertuzumab + Trastuzumab + Docetaxel) in Neoadjuvant Therapy of Early HER-2-Positive Breast Cancer
Effective Pharmacotherapy
Serum Levels of Interleukin 10 (IL-10) in Patients With Type 2 Diabetes
Clinical Biochemistry
Medicine
Clinical Biochemistry
Immune Response to Intrathecal Enzyme Replacement Therapy in Mucopolysaccharidosis I Patients
Pediatric Research
Child Health
Pediatrics
Perinatology
Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience
Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Parental Predictors of Children's Executive Functioning From Ages 6 to 10
British Journal of Developmental Psychology
Developmental
Developmental Neuroscience
Educational Psychology
National Indicators for Quality of Drug Therapy in Older Persons: The Swedish Experience From the First 10 Years
Drugs and Aging
Gerontology
Geriatrics
Pharmacology
